EchoCath of Princeton, NJ, has shipped 50 of its ColorMark needle-biopsy guidance systems to Korean ultrasound vendor Medison. EchoCath said the shipment is the first international delivery of ColorMark, and the company expects to send more ColorMark
EchoCath of Princeton, NJ, has shipped 50 of its ColorMark needle-biopsy guidance systems to Korean ultrasound vendor Medison. EchoCath said the shipment is the first international delivery of ColorMark, and the company expects to send more ColorMark units to Medison in the next year.
ColorMark consists of a driver box that sends minute vibrations through a disposable clip into a biopsy needle, causing the needle to show up as a stripe of color on color Doppler scans (SCAN 5/19/93). EchoCath believes the system can improve visualization during biopsy procedures, such as breast biopsy exams.
In other EchoCath news, the company this month reported revenues for its second quarter (end-February) of $150,000, compared with no revenues in the same period a year ago, before the company had started actively marketing products. EchoCath's net loss for the quarter was $663,000, compared with a net loss of $1.2 million in the second quarter of 1996.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.